Bios Capital Management, Lp Portfolio Stock Holdings
Bios Capital Management, Lp disclosed 6 stock positions valued at approximately $52.9 million in its latest SEC 13F filing. The largest holdings include OPUS GENETICS INC, COGNITION THERAPEUTICS INC, and REIN THERAPEUTICS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 13, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 6
- Portfolio Value
- $52.9M
Holdings by Sector
Bios Capital Management, Lp Portfolio Holdings in Q1 2026
4 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| OPUS GENETICS INC | OCUP | Other | 31.70% | 3,683,429 | - | - | $16,759,602 |
| COGNITION THERAPEUTICS INC | CGTX | Healthcare | 8.63% | 6,000,000 | - | - | $4,560,000 |
| REIN THERAPEUTICS INC | ALRN | Healthcare | 4.87% | 1,982,375 | +291,624 | +17.25% | $2,577,088 |
| LANTERN PHARMA INC | LTRN | Healthcare | 2.24% | 864,435 | -145,072 | -14.37% | $1,184,276 |